M Velia Antonini/X
Oct 24, 2025, 10:16
Marta Velia Antonini: Myth-Busting on Perioperative Autologous Red Blood Cell Salvage
Marta Velia Antonini, Hematologist, Perfusionist ECMO and NRP Specialist and Chair of the Normothermic Regional Perfusion EuroELSO Working Group, shared on X:
“Myth-busting on perioperative autologous red blood cell salvage. Overview of the cell salvage process
- myth: cell-salvaged blood is of poor quality/inferior to allogeneic RBCs: if properly collected/processed, quality of cell salvaged RBCs exceeds allogeneic blood; here some considerations on morphology, oxygen unloading, lifespan, hemolysis, immunological effects
- myth: cell-salvaged blood increases bleeding: residual heparin typically have limited impact… but large-volume acute blood loss still requires factors replacement!
- myth: cell-salvaged blood is not safe in many surgeries: oncologic, obstetric, contaminated surgeries are NOT absolute contraindications… balance/mitigated risks!
- myth: cell-salvaged blood is not cost-effective: generally it is, particularly if employed selectively for high-risk cases
Title: Exploring Myths of Perioperative Autologous Red Blood Cell Salvage
Authors: Kaufman Margit, Jahr Jonathan, Klompas Allan, Perelman Seth, Raphael Jacob, Tan Gee Mei, Frank Steven, Waters Jonathan, Warner Matthew

Open access
Stay informed about latest hemostasis updates with Hemostasis Today.
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at ISTH 2026